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Abstract 
 The serotonin system is considered one of the most complex neuromodulatory systems in 
the central nervous system and is one of the most frequently targeted systems for 
pharmacological studies addressing a wide range of psychiatric dysfunctions. Serotonergic 
neurons are topographically organized with anatomically distinct groups receiving synaptic input 
from specific brain structures, suggesting organization in both function and projection output to a 
wide range of forebrain and brainstem circuits.  There still remains much confusion about the 
role of serotonin, and many of the functions effected by serotonin modulation, including 
affective control, behavioral inhibition and sensorimotor gating, may be linked to the structural 
organization mapped within the system.  The aim of this project is to develop and implement 
labeling methods to visualize and control specific projection pathways of serotonin neurons 
originating in the dorsal raphe nucleus.  Retrograde labeling tools were explored and optimized.  
We were able to optimize the experimental protocol for retrograde labeling using latex 
microspheres, and the results confirmed that there are projections from the dorsal raphe nucleus 
to both the piriform cortex and the olfactory bulb with a majority of these neurons being 
serotonergic.  Piriform cortex projecting cells were more numerous and clustered in the posterior 
portion of the dorsal raphe region.  Two types of retrograde viruses were also tested, though with 
less success and efficiency.  They do, however, offer future possibilities for research exploring 
the structural and functional anatomy of the serotonin system. 
 
 
 
 
 
 
 
 
 
 
KEYWORDS: Serotonin, 5-HT, dorsal raphe nucleus, piriform cortex, olfactory bulb, 
projections, retrograde tracing, retrograde labeling, HiRet, CAV2. 
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Introduction
i
Introduction.	   The serotonin system is considered one of the most complex neuromodulatory systems in 
the central nervous system (CNS) and is one of the most frequently  targeted systems for 
pharmacological studies addressing a wide range of psychiatric dysfunctions.  Anatomical 
studies of the mammalian serotonergic system have significantly enhanced our understanding  of 
its  anatomical and functional organization.  It is widely accepted that serotonergic neurons are 
topographically organized with anatomically distinct groups of subpopulations receiving 
synaptic input from specific brain structures.  The projection patterns of these subpopulations are 
also known to be highly  organized suggesting precision in both control and projection output to a 
number of forebrain and brainstem circuits, which may  have important implications for 
physiological or behavioral functions of the system13.  This project aims to address serotonergic 
subpopulation projection patterns originating in the dorsal raphe nucleus by implementing 
labeling techniques and optogenetic tools which will eventually lead to both anatomical and 
functional exploration of the system. 
Serotonergic System.
 Serotonin is a monoamine neurotransmitter derived from the amino acid tryptophan and 
synthesized by a tryptophan hydroxylase (TPH) and amino acid decarboxylase (DDC) containing 
metabolic pathway (Figure 1).  Also known as 5-Hydroxytryptamine (5-HT), it is found in both 
the Gastro Intestinal (GI) tract  and Central Nervous System (CNS) of mammals, as well as blood 
platelets where 5-HT is carried in large concentrations, but synthesized in small amounts and 
used to assist in homeostatic regulation23.  It has been shown that serotonin is also synthesized in 
the placenta through a direct  placental metabolic pathway that modulates the fetal brain during 
development8.  However, approximately  ten percent of all serotonin is produced in the CNS 
where it is utilized as a neurotransmitter and neuromodulator for a variety of behavioral 
modifications including sensory, motor and emotional responses to external stimuli22.
 The serotonergic system is both one of the evolutionarily  oldest and most complex 
systems in the human brain with neurological pathways projecting to nearly all brain regions.. 
Structurally, this complexity can be attributed in part  to the seven different types and seventeen 
different subtypes of receptors that  are activated by 5-HT and allow for modulation of the 
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system.  Some of the most commonly studied of these include 5-HT1A, 5-HT1B, 5HT2A and C, 
and other pre- and postsynaptic 5-HT receptors14 (Figure 1).  With the exception of the 5-HT3 
receptor, which is a ligand gated ionotropic receptor, all others are G protein-coupled receptors 
(GPCRs) that are divided into four classes depending on the specific functional role in molecular 
signaling.  Structurally, GPCRs cross the membrane seven times and are coupled to G-proteins 
that are intracellularly  released with the binding of 5-HT to the extracellular binding sites61 
(Figure 2).  This release of the G-protein activates diverse signaling cascades depending on the 
specific 5-HT to 5-HT receptor interaction.
 Pharmacological studies have helped to localize these receptors to nearly all brain 
regions, some spanning many regions, others more sparsely localized.  In the cortical brain areas, 
there are at least 6 different sub-types (5-HT1A/B/E, 2A, 5A, and 6) that have been described, 
many of which are correlated to clinical indications related to mood and affect (e.g.. anxiety and 
depression)29, 42.  However, some of these receptors are also found in other regions including the 
Hippocampus, Raphe Nuclei and Basal Ganglia (Table 1).  In addition, some receptors are 
localized to a single specific brain region, such as 5-HT1D found solely in basal ganglia neurons, 
or 5HT2A found in isocortical regions.  Additional brain regions that contain 5HT receptors 
include striatum, hypothalamus, thalamus, cerebellum and amygdala.  Though there is some 
variability among studies, it  is generally  concluded that lower levels of 5-HT and receptors are 
found in the cerebellum and cerebral cortex; higher levels are found in the substantia nigra, 
striatum and hypothalamus; while the raphe nuclei contain the highest levels of 5-HT and 
receptors of all brain regions3, 4.  
  Chapter 1                                                                                                                 Introduction   
3
Figure 1.  Schematic 5-HT (Serotonin) neuron. Tryp (tryptophan) is hydroxylated by 
TrypOHase (Tryptophan Hydroxylase) to form the amino acid 5-HTP (5-hydroxytryptophan).  5-
HTP is converted to 5-HT through decarboxilation by L-AADC (L-amino acid decarboxylase). 
Once packaged into vesicles, it is released into the synaptic cleft  and taken up post-synaptically 
by 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A,C, and other postsynaptic 5-HT receptors, or  pre-
synaptically where it is either broken down by MAO (monoamine oxidase) or transported from 
the synaptic space into the pre-synaptic neuron by a plasma membrane protein, SERT (serotonin 
transporter), where it is then re-packaged into vesicles for future release13, 14.
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Figure 2. Illustration of 5-HT G protein-coupled receptor. The 5-HT1, 2, 4, 5, 6 and 7 
receptors belong to the G-protein coupled superfamily. They are membrane receptors that have 
seven transmembrane spanning a-helices. 5-HT binding to the ‘binding groove’ on the 
extracellular portion of the receptor activates the G-proteins, which initiate secondary messenger 
signaling pathways. The downstream effect is either inhibitory or stimulatory depending on the 
type of G-protein linked to the receptor – 5-HT1 receptors are linked to inhibitory G-proteins, 
whereas 5-HT2, 4, 6 and 7 are linked to stimulatory G-proteins 60, 35.
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Receptor Subtype Brain Regions Clinical Implications
5-HT1A Cortex, Hippocampus, DRN Affective Control
5-HT1B Basal Ganglia, Cortical Regions Pain, Affective Control
5HT1D Basal Ganglia Pain
5HT1E Cortex, Striatum, Hypothalamus Unknown
5HT1F Hippocampus, Cortex Pain
5HT2A Isocortical Regions Affective Control
5HT2B Cerebellum, Lateral Septum, Hypothalamus, 
Amygdala
Unknown
5HT2C Choroid Plexus, Basal Ganglia, Hippocampus, 
Hypothalamus
Feeding; Affective Control
5HT3 Amygdala, Hippocampus Feeding, Digestive Control
5HT4 Basal Ganglia, Hippocampus Affective Control; Learning 
and Memory
5HT5A Cortex, Hippocampus, Cerebellum Unknown
5HT6 Striatum, Cortical Regions Learning and Memory
5HT7 Thalamus, Hypothalamus, Hippocampus Affective Control
Table 1. Localization of 5-HT Receptors in the CNS. General list of localization and clinical 
implications for 5-HT Receptors in the CNS.  DRN (Dorsal Raphe Nucleus)29, 42.
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Dorsal Raphe Nucleus.
 Many of the signaling cascades triggered by the release of 5-HT and its subsequent 
binding to 5-HT receptors originate in the Dorsal Raphe Nucleus (DRN).  The Dorsal Raphe 
Nucleus contains a group of heterogeneous neurons located in the midbrain and Pons region of 
the brain.  The earliest serotonergic studies utilized histofluorescence techniques revealing 
midline DRN localization of 5-HT neurons17, and later staining analysis techniques were 
improved with the implementation of immunohistochemistry using antibodies targeting either 
tryptophan hydroxylase (TPH)32, serotonin (5-HT)64, or serotonin transporter (SERT)76. 
Additionally, mRNA encoding SERT was found in abundance in specific sub regions of the DRN 
that aligned with the distribution patterns associated with TPH in prior immunocytochemical 
studies5.  The organization of the region became defined such that neurons located more caudally 
project to forebrain regions including the septum, hippocampus, and entorhinal cortex, while the 
more rostral neurons project to specific forebrain sites including the caudate putamen, substantia 
nigra, and virtually all neocortical regions57, 64, 39.  
 Being the major source of serotonin to the forebrain, the DRN is only one of a number of 
raphe nuclei.  The earliest histochemical studies were performed in rats and were the first  to 
anatomically divide the Raphe nuclei into clusters each containing afferent and efferent 
projections that are highly  organized22; this distribution of 5-HT neurons was divided into nine 
groups of cell clusters spread throughout the entire Raphe brain region described as B1-B9 
(Figure 4)17.  
 The caudal group  consists of three nuclei spanning the area from the caudal 
metencephalon to the intersection of the pyramidal tract.  The first of these is the most rostral of 
this group, the raphe magnus nucleus (RMg) containing the B3 group  of 5-HT clusters.  The 
second is the raphe obscurus nucleus (ROb) containing the B2 group, and the third is the raphe 
pallidus nucleus (RPa) consisting of the B1 subgroup28 (Figure 4).  The rostral group consists of 
three nuclei spanning the area from the mesencephalon to the mid pons.  The first of these is the 
Caudal linear nucleus (CLi) located midline in the caudal mesencephalon and containing the B8 
group.  The second rostral nuclei is the Median Raphe Nucleus (MRN) containing the second 
largest collection of 5-HT neurons in the brain.  It is divided into the MRN containing the B8 and 
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B5 subgroup, and the pontomesencephalic reticular formation containing the B9 subgroup. The 
DRN is the final of these nuclei that account for approximately one third of all serotonergic 
neurons in the brain and contains the groups B6 (Caudal) and B7 (rostral).  The DRN is further 
subdivided into regions (Figure 5) namely the dorsal division of the dorsal raphe (DRD), 
ventrolateral division of the dorsal raphe (DRVL), ventral division of the dorsal raphe (DRV), 
and intermediate division of the dorsal raphe (DRI).  The DRI consists entirely of serotonergic 
neurons, while the DRV (80%), DRD and DRVL (60%) contain 5-HT in fewer 
proportions28.  
 For many years, this region was thought to be solely serotonergic in property.  However, 
other types of neurotransmitters were discovered including GABA, glutamate, dopamine and 
other peptide transmitters each containing distinct morphologies, projections and neurochemical 
characteristics, which are released or sometimes co-released along with 5-HT by  the neurons in 
this region (Figure 6)48, 28.  The first experiments were conducted using histofluorescence 
techniques and later antibodies were developed against tyrosine hydroxylase (TH) and 
dopamine-β-hydroxylase (DβH) to stain and localize dopamine cell bodies in this region54. 
These studies revealed dopaminergic localization in ventromedial areas with targets to the 
nucleus accumbens, lateral septum and medial prefrontal cortex (MPF)48.  Other similar 
experiments used antibodies against γ-aminobutyric acid decarboxylase (GAD) and GABA-
transaminase (GABA-T) to localize Gabaergic cell bodies52, 53.  Gabaergic neurons in the DRN 
synapse with serotonergic neurons72, which remain the major component of nuclei in this region 
controlling the release of 5-HT to the neocortex32.
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Figure 3.  Schematic drawing depicting the location of the serotonergic cell body groups. 
Sagittal section of the rat central nervous system and their major projections. OT (olfactory 
tuberculum), Sept (septum), C. Put (nucleus caudate-putamen), G. Pal (globus pallidus) T 
(thalamus), H (habenula) S. Nigra (substantia nigra)12, 62.
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Figure 4.  An Illustration of the DRN subdivisions.  (a) Coronal section from The Mouse Brain 
Atlas.  Blue circle localizing the Raphe with (b) a zoomed illustration depicting the DRN 
regions. Aq (Cerebral Aqueduct), DRd (dorsal region of the dorsal raphe), DRv (ventral dorsal 
raphe), DRvl (ventrolateral dorsal raphe), lVn (trochlear nucleus), DRif (interfascicular sub 
nucleus)56. 
!" #"
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Figure 5.  Immunohistochemical staining in DRN.  Two of the DRN neurotransmitters, (a) 
serotonin and (b) dopamine visualized with DAB-immunohistochemistry in coronal rat DRN 
sections. Details of (a) and (b) are seen in (c) and (d), respectively48.
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 Anatomical and Functional Topography
 Anterograde and retrograde tracing tools have widely  been used in mapping what we 
already know of the organization of 5-HT projections in the DRN.  It is accepted that the DRN is 
by definition a single nucleus, yet it contains multiple subdivisions that comprise smaller groups 
of serotonergic neurons with differing characteristics and projections that can been seen 
throughout the entire brain (Figure 6). The patterns of these neurons are highly organized 
suggesting unique functional characteristics that could be associated with the structural mapping 
of the system.  For example, serotonergic neurons located more caudally project selectively to 
specific forebrain sites (e.g., the septum, hippocampus, and entorhinal cortex), while serotonergic 
neurons located more rostrally project to other forebrain sites (e.g., the caudate putamen, 
substantia nigra, and almost all neocortical regions).  This means that some functional specificity 
can be attributed to the structural organization within these subpopulation regions of the DRN 64.
 The earliest experiments exploring structural organization used retrograde labeling tracers 
injected into different, but functionally related sites in the forebrain22.  Retrograde tracers were 
injected in pairs (caudate putamen paired separately with the substantia nigra, amygdala, 
hippocampus, and locus ceoeruleus (LC); amygdala with hippocampus, LC;  and hippocampus 
with LC).  Results were similar to subsequent findings; the rostral part of the DRN sends 
collateral projections to the caudate putamen, while caudal parts send projections to regions of 
the limbic system such that these collateral serotonergic projections could allow modulation of 
specific neural circuits implicated in affective functioning and control including conditioned fear 
and stress response40.  This sets up a hypothesis that different regions of the DRN could have 
specific and organized functional characteristic based on projection targets of that region.
	
 Additionally, the dorsal part of the DRN (DRD) projects to the amygdala, hypothalamus, 
nucleus accumbens and prefrontal cortex; the median raphe nucleus (MRN) to septohippocampal 
system and to cortical regions involved in the regulation of the hypothalamic–pituitary–adrenal 
(HPA) axis69; the ventral part of the DRN (DRV) to the caudate putiman, sensorimotor cortex, 
frontal cortex and motor cortex; the ventral lateral (DRVL) to the sympathomotor control system, 
subcorticol structures and DRV; and the lateral vestibular nucleus to the dorsal/ventral 
hippocampus, medial septum and cortical regions22. 
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 Specific bundles of 5-HT subpopulations are found within subregions.  It is clear that the 
organization at present remains complex and broad, yet it serves as a general map of subregion 
organization that might be used as a starting point for further experimentation of DRN labeling. 
The literature also suggests variable definitions to distinguish these subgroups within the DRN, 
with some definitions of caudal regions being the same as others’ definitions of rostral 59, 37, 41. 
The questions remain whether we can further understand the organization of these subregions, 
whether a universal acceptance of subregion divisions can be defined and whether these specific 
subpopulations can be associated with sensory input and behavioral output patterns.  The more 
the anatomical specificity  of these projections and their organizational patterns with the DRN is 
elucidated, the more this information will be utilized to control and manipulate specific 
serotonergic brain circuits, which will lead to a further understanding of the multifaceted 
functions of this system.
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5-HT and Behavior
 Perhaps the view supporting functional heterogeneity of the DRN is more realistic and 
accepted among researchers compared to a single function hypothesis.  5-HT has been shown to 
play  a key role in the regulation of physiological, cognitive and affective processing including 
sleep, mood, feeding, thermal regulation, and memory; therefore dysfunction or disruption of the 
system is linked to a number of disorders ranging in scope from physiological to psychiatric 
classification.  Additionally, there remains much confusion about the role of 5-HT, which is not 
surprising considering the vast complexity of the system, the broad anatomical connectivity  of its 
projections and the paradoxical nature as it relates to behavior.
 Affective Control
 Serotonin is one of the most important targets for pharmacological studies addressing 
mood disorders (ie., depression, anxiety, panic attacks and aggressive behavior)19.  The earliest 
studies to link 5-HT to mood measured serotonin levels in the cerebral spinal fluid of humans 
diagnosed with major depressive disorder.  These patients showed low-levels of serotonin 
metabolites, as well as decreased levels of available L-tryptophan in the blood plasma15.  More 
recently, serotonin depleted animal models are being used to study the effects of serotonin on 
behavior.  Tph2-deficient (Tph2−/−) mice have been used to evaluate the impact of serotonin 
depletion during a number of behavioral tasks designed to evaluate depressive-like behaviors in 
animals.  Tph2−/− mice exhibited increased depression-like behavior in the forced swim test, 
showed decreased anxiety-like behavior in the elevated plus maze task, and exhibited aggressive-
like behavior during the resident-intruder paradigm51.  These results support the hypothesis that 
low-serotonin levels are linked to depressive-like symptoms, as well as aggressive-like behavior.  
 However, the paradox of 5-HT emerges in that 5-HT is implicated in both depression and 
anxiety, as well as panic disorder and aggression, such that the system produces contradictory 
responses to 5-HT dysfunction13.  This is also seen within the framework of current 
pharmacological treatments most widely used to reduce anxiety in psychiatric conditions, such as 
selective serotonin reuptake inhibitors (SSRIs) by increasing 5-HT transmission27, and 
benzodiazepines by reducing 5-HT transmission13.  It is unclear how one system has the ability, 
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both on its own and in tandem with other neuromodulatory systems, to control and regulate such 
a wide range of behaviors that are at times contradictory in function.  The brain circuitry 
involved is also not well-defined, but much of the research points to the limbic brain areas as 
possible targets for affective control67.  The limbic brain circuitry includes  a number of neural 
pathways such as corticolimbic, dorsal raphe, hippocampal, amygdalar, striatal and mesolimbic 
dopamine circuits.  The limbic circuit  is a target of interest not only  in affective control, but in 
memory, learning, motivation and olfaction, and is known for its control of the ‘fight or flight’ 
mechanism in mammels.  Serotonin projecting neurons from the DRN target the limbic brain 
areas and are often a focus in serotonin research as it  relates to emotional control processes, 
affective dysfunction and treatments for a wide range of affective disorders (Figure 7)73.  
 5-HT can also mediate and interact with other neuromodulators including dopamine, 
GABA and glutamate in order to exert its role in affective functioning19.  For example, 
corticotropin-releasing factor (CRF) has been shown to modulate serotonergic neuron activity 
through its interaction with GABAergic neurons in the DRN, and that CRF receptors upregulate 
and downregulate GABAergic neurons, which inhibit 5-HT neurons.  Additionally, Galanin, a 
neuropeptide encoded by the GAL gene, has been shown to have antidepressant-like effects 
through the upregulation of serotonergic transmission via galanin receptors on 5-HT DRN 
neurons48.  Additionally, other theories have been proposed that suggest that rather then exerting 
direct affective control, 5-HT could either be modulating representational and functional 
responses to aversive events such that aversive processing can change in response to the level of 
serotonin available at it’s receptors, or alternatively 5-HT’s affective outcomes could be a result 
of behavioral inhibition16.
 Behavioral Inhibition
 Early behavioral studies suggested the involvement of serotonin as a neuromodulator in 
withholding responses particularly  when linked to aversive stimuli, such that  lowered serotonin 
transmission produced a decrease in withholding punished responses63.  More recently, 
neuroscientists are trying to separate these two areas, behavioral inhibition and aversive 
response, by either suggesting a distinct role for serotonin in aversive processing, or proposing a 
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more general role for serotonin in behavioral inhibition16.  It has been shown that aversive events 
such as inescapable shock activate the release of 5-HT from neurons66, but depleted serotonin 
levels are correlated with an increased behavioral response to aversive cues and contexts63, and 
temporarily lowering serotonin in humans seems to enhance aversive processing in cognitive 
tasks13.  Paradoxically, these studies suggest that if 5-HT is involved in aversive processing, then 
depleting it should have positive affective consequences as opposed to the many studies linking 
low 5-HT levels to depressive-like symptoms19, so these contradictory  findings are difficult to 
understand.
 More recently, acute tryptophan depletion has been used to study the effects of low 
serotonin levels to try understand and separate the hypotheses that link serotonin to motor 
response inhibition, punishment-induced inhibition, or affective sensitivity to aversive outcomes. 
In human studies, subjects given placebo were slower to respond under punishment conditions 
compared to reward conditions, while tryptophan depletion abolished this punishment inhibition 
response and did not have any affect on motor response or the ability  to adjust response to 
punishment conditions.  Additionally, the level of reduction in punishment-induced inhibition 
depended on the degree of reduced plasma tryptophan levels. These findings support the current 
hypotheses linking serotonin to aversive processing and aversive outcome prediction. as opposed 
to motor response inhibition16.
 However, it has also been argued that the behavioral inhibition that results from aversive 
outcome prediction is not sufficient to explain some forms of impulsive behavior in animals. 
Recent microdialysis and unit recording studies examined the 5-HT neuronal activity  in behaving 
animals and found an increase in 5-HT release when rats performed a task that required waiting 
for delayed reward49, 50.  Other results have confirmed an increase in serotonergic neuronal firing 
that facilitates waiting behavior when linked to a future reward.  This suggests that the inhibitory 
effect of 5-HT is not solely linked to aversive prediction.  The medial prefrontal cortex (mPFC) 
and Orbitofrontal (OFC), both of which have reciprocal connections with the DRN, are brain 
regions involved in waiting tasks.  They have been shown to sustain increased activity during 
waiting for delayed rewards, however the role of the OFC does not seem to contribute directly to 
response inhibition, but rather to signal expected outcomes to other brain regions49, 50.  The OFC 
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circuit has both efferent and afferent connectivity  to both limbic and motor control regions as 
well causing an ongoing debate as to whether the behavioural inhibition associated with raised 
levels of 5-HT is best explained in motivational or motor terms13.
 
 Sensorimotor Gating
  Although there is little information regarding the mechanistic circuits for 
serotonin’s role in motor inhibition under non-punishment conditions in humans and rodents11, 20, 
there is evidence that points to both motor connectivity of serotonergic pathways and 
sensorimotor modulation in various sensorimotor modalities.   The earliest motor studies used 
serotonergic pharmacology to study effects of 5-HT perturbations on motor function in rats 
resulting in symptoms of hyperactivity and tremors, or an increased amplitude motor response in 
hind limb function in cats65, 6.  It has also been suggested that 5-HT modulates respiratory 
activity, as well as feeding, avoidance and escape behavior19.
 Anatomically, there is evidence supporting motor influence of 5-HT projections on 
behavior.  For example, the brain stem and spinal cord α-motoneurons receive serotonergic 
inputs in the ventral horn, the motor nucleus of the trigeminal, and the facial motor nucleus31.  In 
the spinal cord, serotonergic inputs innervate motoneurons projecting to axial rather than distal 
structures, while inputs to the brain stem are directed toward large projections of jaw, face and 
neck muscles.  5-HT neurons also innervate secondary structures such as substantia nigra, globus 
pallidus and habenula, all structure associated with motor and/or sensory  function.  Jacobs and 
Fornal31 propose an interesting hypothesis suggesting when motor activity  is initiated, sensory 
information processing is suppressed, so that 5-HT neurons play a continuous inhibitory role in 
sensory transmission. 
 In rodents, smell is behaviorally the most relevant sensory  modality.  In the olfactory 
bulb, which is the first stage of olfactory  information processing, serotonergic fibers that 
originate in the brainstem raphe nuclei preferentially project to the glomerular layer of the 
olfactory bulb46, and according to one study, 5-HT released from the raphe nuclei inhibits 
glomurular activity58.  Raphe neurons are known to modulate their activity in longer time scales 
with different states of wakefulness and arousal, and in shorter time scales in response to salient 
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events.  These findings support  the hypothesis that an increase in firing of raphe neurons, which 
may occur during periods of higher sniffing rate, leads to a decrease in the sensory evoked 
activity in the olfactory bulb. It  is therefore hypothesized that  the overall gain of olfactory  input 
is reduced by 5-HT to keep the postsynaptic responses in a normal dynamic range58 to prevent 
them from  being saturated supporting prior theories relating 5-HT to sensorimotor gating. 
Additionally, the second stage of olfactory  processing, Piriform Cortex (PC), is also densely 
innervated by 5-HT fibers originating in the DRN.  However, the functional role of 5-HT in the 
PC is poorly understood.  
 Many of the functions effected by serotonin modulation are directly linked to the 
structural projections previously  mapped within the system.  There are some common 
characteristics shared by affective control and inhibitory  and sensorimotor processes associated 
with these 5-HT pathways and disentangling the complexity of 5-HT system on both an 
anatomical and functional level will help to understand these characteristics more clearly.
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Figure 6. 5-HT Projections from the DRN to limbic brain areas.  Serotonin pathways in blue 
project from the DRN to nucleus accumbens, hypothalamus, hippocampus and amygdala, while 
glutamate pathways in green project from the medial Prefrontal Cortex (mPFC) to these same 
regions.  Treatments for depression exert effects on either the DRN or mPFC; SSRIs to the 
serotonin pathway, and Cognitive Behavioral Therapy to the glutamate pathway73.
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Retrograde Labeling Methods
 Retrograde labeling tools are used to assist neuroscientists in understanding how neurons 
generate behavior by mapping circuitry within the CNS.  The functions of the brain are based on 
the activity  patterns of large populations of interconnected neurons that form neural circuits. 
Each type of retrograde tracer has its own set of characteristics that determine the scope of 
problems it  can address.  Retrograde tracers are injected into the projection site, taken up by 
axons and carried to cell bodies where they are expressed.  There are both advantages and 
limitations to using any of the diverse range of retrograde tracers available.
 Latex Microspheres.
 Latex microspheres have commonly been used to study structural anatomy within the 
CNS.  They are 0.02mm polymeric particles that have been suspended in latex and tagged either 
with green (fluorescein) or red (rhodamine) fluorescent markers.  Once injected into the region 
of interest, they take a relatively  short  time to express within cells bodies, are known for their 
ease-of-use, high transport efficiency, distinctive cell labeling, the ability to produce well-defined 
injection sites and can be imaged using fluorescence microscopy1 (Figure 7).  They have 
successfully  been used for decades to map anatomical projections in the CNS.  The earliest 
studies looked at retrograde transport in cat visual cortex slices and revealed significant 
differences in patterns of intrinsic axonal and dendritic arborization34.  Today, they are widely 
used as a general anatomical marker in many experimental protocols.  Latex microspheres 
provide a means of visualizing pathways of interest, but are limited to structural anatomy; they 
cannot be used for studying functional anatomy or behavior. 
 Viruses. 
 Retrograde virus methods can reveal mono- or multi-synaptic pathways and can identify 
connections to and from particular cell types to guide functional studies that have higher 
components of complexity.  Viruses are injected into the target  region and transported 
retrogradely  to cell bodies where transgene expression takes place (Figure 8). There are different 
types of viruses and techniques that can be used each with advantages and limitations.  Some 
advantages are the ability to traverse multi-synaptic pathways, the ability of viral replication and 
  Chapter 1                                                                                                                 Introduction   
20
high specificity to synaptically connected partners38.  However, some limitations include 
difficulty in cell infection, difficulty  in retrogradely  transporting large constructs from the 
injection site especially over longer distances, and a lack of cell-type specificity.  
 A Cre recombinase-dependent system can be implemented to help  solve the limitations of 
cell type specificity and construct size2 (Figure 9).  There are two strategies that can be utilized 
for visualizing and eventually controlling specific cell types.  One is to inject a retrograde virus 
containing a vector with a specific promoter, such as Pet1 for serotonin neurons, into a target 
region in a transgenic mouse containing a stop  codon between loxp recombinase sites that is 
followed by genes of interest (these genes may be for example Channelrhodopsin-2 for 
controlling neuronal activity or enhanced yellow fluorescence protein for visualization).  When 
the virus interacts with the loxp site, the stop is excised only in cells expressing genes under the 
specific promoter.  The second strategy is to inject a virus containing genes of interest and loxp-
sites into a transgenic mouse in which Cre is expressed in only a subset of neurons (such as the 
SERT-Cre mouse for serotonin specific neurons), so that only cells expressing Cre will express 
the genes of interest following virus injection.  These techniques are useful both for visualizing 
projection pathways, and for future use with Optogenetic strategies.
 Rabies Virus.
 Rabies Virus (RV) is useful in its ability to spread transynaptically solely in the 
retrograde direction, and infected cells stay viable for weeks.  It also has the ability to amplify 
from one single particle making it  highly efficient74.  The single biggest drawback in using RV is 
that it is a negative strand RNA virus, which makes it difficult to develop novel variants 
necessary  for use with genetic tools and transgenic mouse lines.  Although recovery of new RV 
variants is difficult, it can be accomplished; recent production of a new SADΔG variant and an 
efficient method for recovery and amplification55 was established, so that variants that encode a 
multitude of tools were developed including fluorescence proteins, Channel Rhodopsin-2 
(ChR2), and flippase (FLP) recombinase.  However, these are difficult to acquire, and RV is 
highly  toxic in property, which makes it a less desirable candidate when other options are 
available.  
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 Adeno-associated Virus.
 Adeno-associated Virus (AAV) is a single stranded virus for which nine serotypes have 
been described with humans as the primary host.  It can be used for retrograde tracing and is an 
ideal candidate in that it lacks pathogenesis.  It can infect both dividing and non-dividing cells, 
has the ability to persist for long periods.  It has limited retrograde transport ability, so injecting 
an AAV into a target region may not result in efficient transport along axons. (Figure 9b) (Table 
2).
 Canine Adenovirus Type 2
 A high level of retrograde transport and preferential transduction of neurons make Canine 
Adenovirus Type 2 (CAV2) vectors ideal tools to study the pathophysiology of neuronal 
networks, as well as map complex circuits in vivo.  CAV-2 vectors have been used in conjunction 
with Cre recombinase system and has been shown to express more effectively  then AAV25, 26. 
Because CAV-2 is more difficult to clone compared to AAVs achieving cell-type specificity  is 
more challenging (Table 2). 
 Highly Efficient Retrograde Gene Transfer.
 The highly  efficient retrograde gene transfer (HiRet) is a pseudotype of the HIV-1 
lentiviral vector with FuG-B, which is composed of the extracellular and transmembrane 
domains of RV-G and the cytoplasmic domain of VSV-G, which will introduce a transgene into 
neurons that innervate a particular brain region at the vector injection site and confer a 
fundamental tool for genetically manipulating specific neural pathways33.  Compared to other 
viruses, HiRet is easier to clone.  This offers an option for injecting HiRet with a serotonin-
specific promotor (HiRet-Pet1-Cre) into the target region of ChR2 transgenic mouse (Rosa26-
LSL-ChR2H134R-EYFP), which would allow for highly efficient retrograde transport and 
serotonin specificity.  However, since this is a novel approach, it will take time to develop  and 
optimize (Figure 9a) (Table 2).
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Figure 7.  Typical injection sites using red and green latex microsphere. (a, b) Caudal 
brainstem injection in rat using red (a) and green (b); (c, d) Lumbar spinal cord using red (c) and 
green (d)1.
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Figure 8. Schematic of virus transport and expression.  Viral vectors are injected into 
projection site of interest, then picked up by nerve terminals and retrogradely  transported along 
axons until they reach cell bodies where transgene expression takes place33.
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Figure 9. Cre-lox recombinant system.  Design and Characterization for (A) Virus containing 
Pet1-Cre for serotonin specificity injected into transgenic mouse line (Rosa26-LSL-
ChR2H134R-EYFP).  When Cre interacts with the loxP sites it will excise the stop and 
expression of ChR2-eYFp will be seen in serotonin cells.  (B) Virus containing flexed ChR2-
eYFP is injected into a SERT-Cre transgenic mouse.  When Cre, which is expressed only in 
serotonin cells, interacts with loxP sites, the genes are inverted and ChR2-eYFP is expressed in 
serotonin cells. 
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Virus Construct/Strategy Pros Cons Reference
RV Unavailable Good	  retrograde	  
transport,	  good	  viability
Toxic,	  difficult	  to	  develop	  
new	  variants
Osakada	  et	  al.,	  2011
AAV Double	  floxed	  ChR2	  injected	  
into	  a	  SERT-­‐Cre	  mouse
Good	  axonal	  and	  cell	  type	  
specificity
Difficult	  to	  clone,	  limited	  
retrograde	  transport
Betley	  and	  Sternson,	  
2011
CAV2 Double	  injecNon:	  General	  
promoter	  Cre	  in	  target	  
region	  +	  double	  floxed	  ChR2	  
in	  DRN
Good	  retrograde	  
transport
No	  cell-­‐type	  specificity Hnasko	  et	  al.,	  2006
HiRet HiRet-­‐Pet1-­‐Cre	  injected	  in	  
target	  region	  of	  ChR2	  
transgenic	  mouse	  (ai32)	  
Good	  specificity Unknown	  viability,	  
relaNvely	  new	  virus
Kato	  et	  al.,	  2011;	  
Kinoshita	  et	  al.,	  2012
Table 2.  Retrograde Virus Possibilities for Proposed Study.  Table depicting the advantages 
and limitations of different viral vectors and strategies for mapping of serotonin circuits in the 
CNS.
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Aim of Proposed Study.
 The aim of this project is to develop and/or implement labeling methods to visualize and 
control subpopulation projection pathways of 5-HT neurons originating in the dorsal raphe 
nucleus.  This project  will be twofold.  First, retrograde labeling tools will be explored and 
optimized.  This will include the use of retrograde latex microspheres and the development of 
viral strategies as tools for optogenetic control.  The first stage will be to optimize the following: 
stereotaxic coordinates for injection sites in the regions of interest, experimental protocols (i.e., 
immunohistochemistry) for visualizing co-localization of cells, as well as imaging and analysis 
techniques.  Second, will be to gain a structural understanding of the localization patterns of cells 
originating in the DRN and projecting to the regions of interest, and to determine whether or not 
these cells contain 5-HT.  The regions of interest include the Piriform Cortex (PC) and Olfactory 
Bulb (OB) as they receive projections from the DRN. 
   
 Piriform Cortex
 5-HT projections have been documented from the Raphe to the PC using retrograde 
labeling of Cholera-toxin B coupled with immunohistochemistry  with specific cells labeled in 
the medial ventral DRN18.  There is known to be high 5-HT innervation in this region, as well as 
non-serotonergic innervation from the mitral cell layer of the olfactory bulb24, which will offer a 
clear landmark to visualize the integrity of the retrograde tracer and the accuracy of the injection.
  
 Olfactory Bulb
 There is some ambiguity  regarding known projections to the OB from the midbrain raphe 
with some studies supporting a prominent role for DRN projections, while other studies argue for 
MRN.  Importantly, it is not known whether the 5-HT neurons that project to OB are the same 
neurons that project  to PC.  This may have significant implications for the functional impact of 
5-HT on the olfactory system.
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Materials.
 Dolorox and Trivertan were purchased from Intervet Schering-Plough (Paço de Arcos, 
Portugal).  Visidic Gel was purchased from Angelini Farmacêutica Lda (Bausch & Lomb) 
(Oeiras, Portugal).  Isofuorene was purchased from Vetfluor Virbac de Portugal Laboratórios Lda 
(Sintra, Portugal).  Saline was purchased from B. Braun Medical, Lda (Queluz de Baixo, 
Portugal).  Gentimiacin, Paraformaldehyde, Sodium hydroxide, Monopotassium phosphate, 
Disodium phosphate, Sucrose, Tris-sodium Citrate containing Tris, Hydrochloric Acid, Triton 
X-100, Tris Buffered Saline containing Tris, Sodium Chloride and Potassium Chloride, 10% 
bovine serum albumin diluent blocking solution and Mowiol were purchased from Sigma-
Aldrich (Sintra, Portugal).  5% Goat Serum was purchased from Life Technologies (Barcelona, 
Spain).  Red Lumafluor Retrobeads™ IX and Green Lumafluor Retrobeads™ IX were purchased 
from Lumifluor Inc. 
 Antibodies.
 Monoclonal Anti-Tryptophan Hydroxylase antibody produced in mouse (α-TPH) (T0678 
Sigma) was purchased from Sigma Aldrich.  Alexa Fluor® 488 Rabbit Anti-Mouse IgG (H+L) 
labeled with bright, photostable, green-fluorescent Alexa Fluor 488 dye and Alexa Fluor® 647 
Goat Anti-Mouse IgG (H+L) labeled with bright, fluorescent far-red Alexa Fluor 647 dye 
prepared from affinity-purified antibodies that react with IgG heavy chains and all classes of 
immunoglobulin light  chains from mouse were purchased from Life Technologies (Porto, 
Portugal).  DAPI Nucleic Acid stain was purchased from Sigma Aldrich (Sintra, Portugal). 
Animals.
 8-12 week old male (250-300g) Sert-CRE or Ai32 (Rosa26-LSL-ChR2H134R-EYFP) 
transgenic mice were used.  Animals were housed in group  cages with ad libitum access to food 
and water. The room was maintained at 21°C, on a 12h:12h light/dark cycle (8am-8pm), with a 
light intensity  of 323-377 lux and humidity  of 30-70%.  All procedures were performed in 
accordance with the Champalimaud Foundation Ethics Committee guidelines, and approved by 
the Portuguese Veterinary General Board (Direcção Geral de Veterinária, approval ID 014315).
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 Generation of transgenic mice. 
 The Slc6a4-Cre line (ET33, also called SERT-Cre)21 was obtained from MMRC (Mutant 
Mouse Regional Resource Center) and were then produced by breeding +/+ and SERT-Cre/+ 
mice.  The Ai32 line (Rosa26-LSL-ChR2H134R-EYFP)43 was obtained from The Jackson 
Laboratory.  The Double transgenic mice SERT-Cre/+; Rosa26-LSL-ChR2/+ were produced by 
breeding SERT-Cre/+ and Rosa26-LSLChR2/+ mice.
Surgeries.
 Mice were initially anesthetized in an induction chamber primed with isofluorane, then 
mounted and stabilized on a stereotaxic frame where they were maintained in an anesthetized 
state using a gas mixture with oxygen (1 L/min) and isofluorane (1.5 - 2 L/min).  Subcutaneous 
injections of Dolorox (0.1ml in 9.9ml 0.9% Saline, 0.1ml/10g) and Trivertan (0.04ml in 9.96ml 
0.9% Saline, 0.1ml/10g) were administered each in 0.25-0.30ml doses prior to incision.  A 
midline incision was made exposing the skull, and Bregma and Lambda were aligned and used 
as points of reference.  A small hole was drilled into the skull using a dental drill at points 
corresponding to the injection locations listed below.  Injections were made using a Picospritzer 
III (Intracel) fixed with a quartz micropipette (tip  size 1.0 mm).  Solutions were injected at a rate 
of approximately 0.04µl/min.  The pipette was held in place for 5 minutes after injection, then 
immediately retracted.  The head skin was then sutured and an application of Gentimiacin 
(0.3% in 0.9% Saline) was administered.  Mice were housed individually post-surgery and 
sacrificed 2-5 weeks after injections as outlined below according to the type and location of 
retrograde tracer being injected.
Retrograde Tracers.
 Latex Microspheres.
 Red or Green IX (undiluted) Lumafluor Retrobeads™ (0.125µl) were injected into the 
Piriform Cortex (from Bregma, 2.5mm lateral; from midline, 2.2mm anterior; from dura 3.4 mm 
deep), the Olfactory  Bulb (from Bregma, 0.75mm lateral; from midline, 4mm anterior; from 
dura, 0.75mm deep), Raphe (from Bregma, -4.75mm; from midline, 0mm; from dura, 3.1 at an 
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angle of 32°) or VTA (from Bregma, -3 mm; from midline, 0.5 mm; from dura, 4 mm) 
corresponding to coordinates laid out in the The Mouse Brain in Stereotaxic Coordinates56. 
Beads were stored at 7°C and protected from light.  A post-injection survival time of 2 weeks 
was adhered to to allow for complete transport of beads to the Raphe, though no increase in 
fluorescent intensity is observed after 48 hours.
 Virus Generation.
 The AAV2/1.EF1a.double floxed ChR2.EYFP was purchased from the Penn Vector Core, 
School of Medicine, University of Pennsylvania (USA).  The CAV2-Cre and CAV2-GFP viruses 
were a gift of Eric J. Kremer (Institut de Génétique Moléculaire de Montpellier CNRS-UMR 
5535 - 1919, Route de Mende - 34293 Montpellier, France).  The lentivirus DNA Hi-Ret-MSCV-
GFP was a gift of Kazuko Kobayashi (Department of Molecular Genetics, Institute of 
Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan). 
The virus was produced by the CCU Vector Production Platform (Tatiana Vassilevskaia).  The 
Hi-Ret-Pet1-Cre DNA construct was cloned by Enrica Audero of CCU by replacing MSCV-GFP 
with Pet1-Cre. 
Tissue Preparation
 The mice were anesthetized with an intraperitoneal injection of Eutasil (.025-.030), then 
perfused transcardially with 4% paraformaldehyde (4% PFA) in 0.1 M  phosphate buffer (PB). 
The brains were postfixed overnight in 4% PFA solution, then immersed for 48 hours in PB 
containing 30% sucrose. Coronal sections (12-20 µm thick) were prepared using a cryostat, and 
slices were then mounted and sealed or left at room temperature for immunofluorescence 
staining.  
Immunofluorescence Staining.
 For immunostaining, heat induced unmasking was performed on Raphe sections (12-20 
µm thick) followed by  3 times wash in Tris-buffered saline pH 7.5 (TBS).  Slices were then 
blocked in a blocking solution containing 5% Goat Serum, 2% bovine serum albumin (BSA), 
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and 0.25% Triton X-100 in TBS for 1 hour followed by 3 times wash in TBS pH 7.5 and an 
immediate incubation in Monoclonal Anti-Tryptophan Hydroxylase antibody  produced in mouse 
(α-TPH) diluted 1:400 in blocking solution containing 5% Goat Serum, 2%, BSA and 0.25% 
Triton X-100 in TBS for 1 hour at room temperature.  As the secondary antibodies, Alexa Fluor® 
488 Rabbit Anti-Mouse IgG (α-mouse) diluted 1:1000 in blocking solution containing 5% Goat 
Serum, 2%, BSA and 0.25% Triton X-100 in TBS and Alexa Fluor® 568 Goat Anti-Mouse IgG 
(α-mouse) diluted 1:1000 in blocking solution containing 5% Goat Serum, 2%, BSA and 0.25% 
Triton X-100 in TBS were used depending on the desired fluorescence.  Dapi staining was used 
as a control for all experiments and coverslips were mounted and sealed using Mowiol.
Image Acquisition and Analysis.        
 Images were acquired using an upright Widefield Fluorescence Microscope equipped 
with a motorized stage for tiled image acquisition and stitching (Carl Zeiss Axioimager.M2) 
controlled with Axiovision 4.8.2 software.  Each image was acquired using an EC Plan-Neofluar 
20x/0.50 objective and filtersets corresponding to four different wavelengths. DAPI fluorescence 
was detected using a G365 excitation filter (emission peak: 365 nm), a 395 nm dichroic mirror 
and BP 420-470 nm emission filter. GFP fluorescence was detected using a high efficiency 
filterset consisting of a BP 450-490 nm excitation filter, a 495 nm dichroic mirror and a BP 
500-550 nm emission filter. DsRed fluorescence was detected using a high efficiency filterset 
consisting of a BP 538-563 nm excitation filter, a  570 nm dichroic mirror and a BP 570-640 nm 
emission filter. Cy5 fluorescence was detected using a BP 625-655 nm excitation filter, a 660 nm 
dichroic mirror and a BP 665-715 nm emission filter. Tiled images were acquired in brightfield 
and fluorescence with exposure times optimized for each channel and stitched together using the 
AxioVision software. An in-house developed Matlab application was used to visualize merged 
images and identify beads in the Raphe. Cells were counted manually; beads were counted in the 
Raphe, and then categorized according to the positive or negative co-localization with 5-HT 
cells.
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Retrobeads.
 In the first part of this study, retrograde latex microspheres (Lumifluor Retrobeads) were 
injected in either the Piriform Cortex or Olfactory Bulb to analyze transport  to and localization in 
the Dorsal Raphe Nucleus.  Cell counting was performed manually, and co-localization was 
detected to compare the total number of retrogradely  labeled cells to the labeled cells co-
localized with 5-HT as identified using immunohistochemistry.
 Injection Sites.
 Initial injections targeting Piriform Cortex (PC) according to coordinates derived from 
The Mouse Brain Atlas56, missed the target. Therefore, recalibration of the injection sites was 
necessary  using different antero-posterior levels until optimal coordinates were confirmed.  Brain 
slices were imaged for retrobead injections for Piriform Cortex (PC) at optimal coordinates 
(from Bregma, 2.5mm lateral; from midline, 2.2mm anterior; from dura 3.4 mm deep) (Figure 
10a) and for Olfactory Bulb (OB) at optimal coordinates (from Bregma, 0.75mm lateral; from 
midline, 4mm anterior; from dura, 0.75mm deep) (Figure 11a) as was confirmed in The Mouse 
Brain in Stereotaxic Coordinates56.  Coronal sections were obtained and imaged according to 
protocols laid out in the Methods section.  Both PC and OB injections were effective and 
sufficient.
   
 Retrograde Tracing.
 Retrobead retrograde transport was effective for the PC injection as there was transport 
from the injection site to the mitral cell layer of the Olfactory Bulb (Figure 10b), which is the 
major source of afferent input to the PC24.  There was also effective retrograde transport from the 
PC to the DRN, specifically the medial portion of the DRN (Figure 10c).  Immunohistochemical 
staining for TPH (a serotonin specific marker) was effective and merged images show co-
localization of retrogradely labeled cells with TPH positive cells.
 It was previously shown that the PC receives both 5-HT and non-5-HT projections from 
the DRN, which is confirmed by the present results as ~80% of PC projecting DRN neurons 
were TPH positive (n=1 mouse; Figure 12).  These results also confirm previous retrograde 
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tracing studies that used cholera-toxin B as a retrograde tracer showing direct 5-HT and non-5-
HT projections from the DRN to the PC and report ~70% of projection neurons as being 
serotonergic18.
 Retrobead retrograde transport was also effective for the OB injection (n=1 mouse; 
Figure 11b).  Immunohistochemical staining for TPH was effective, and merged images show 
retrogradely  labeled cells co-express TPH and beads. While the proportion of 5-HT projection 
neurons was similar to that found in PC at ~85%, the total number of neurons was considerably 
smaller.   One possible explanation for the low expression of labeled cells in the OB could be 
that the injection did not  target the glomurular layer (Figure 11a), which was shown to receive 
dense 5-HT input46 such that a more precise injection could give more accurate and denser 
labeling of DRN cells. 
 Spatial distribution.
 Next, the spatial distribution of PC projecting DRN neurons was determined. To do so, 
the number of PC projecting DRN neurons was counted in consecutive coronal brain slices and 
the number of cells was plotted against the anatomical location, measured as distance from 
bregma (n=3 mice, Figure 13a,b). Unfortunately, these brains had poor immunohistochemical 
signal and therefore only the total number of projection neurons is considered regardless of their 
neurochemical identity. However, given the large proportion of 5-HT projection neurons (Figure 
12c), these results likely  reflect the distribution of 5-HT neurons as well.  These figures show a 
clear bias in the distribution of PC projecting DRN neurons with most of the neurons located in 
the posterior caudal portion of the DRN.  Additionally, as can be seen in Figure 13c, most of the 
neurons are located medially.  
 In conclusion, these results confirm that there are projections to each region originating in 
the DRN, and a majority  of these cells are TPH positive. They also suggest that PC receives a 
much larger serotonergic input. Further analysis of the spatial distribution of these neurons 
within the DRN reveals a highly non-uniform pattern. This meshes well with the idea that the 
DRN rather than being a spatially  uniform nucleus broadcasting a unitary  signal, is actually 
highly  heterogeneous, containg various subpopulations of spatially distinct groups of neurons 
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each with distinct projection pattern.  Finally, it is evident that  retrobead transport  is effective and 
the method is useful for anatomical tracing of the serotonergic system.
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Figure 10. Retrogradely labeled cells from the PC injection site.  A) (left) Atlas illustration 
depicting coordinates for Piriform Cortex injection site (from Bregma, 2.5mm lateral; from 
midline, 2.2mm anterior; from dura 3.4 mm deep); (right) Injection site of red retrobeads into 
PC.  B) (left) Atlas illustration depicting coordinates for Olfactory Bulb; (right) mitral cell 
labeling in OB from retrobeads retrogradely  transported from PC.  C) (left) Atlas illustration with 
lines depicting DRN corresponding to images; (1) Red retrobeads showing DRN labeled cells 
that project to PC; (2) TPH staining for 5-HT cells in DRN; (3) Merged image depicting 5-HT 
expressing PC projecting cells; (4) Zoomed image of co-labled cells in DRN; white arrows show 
beads co-localized with 5-HT. 
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Figure 11. Retrogradely labeled cells from the OB injection site.  A) (left) Atlas illustration 
depicting coordinates for Olfactory  Bulb injection site (from Bregma, 0.75mm lateral; from 
midline, 4mm anterior; from dura, 0.75mm deep); (right) Injection site of red retrobeads into 
OB.  B) (left) Atlas illustration with lines depicting DRN corresponding to images; (1) Red 
retrobeads showing DRN labeled cells that project to OB; (2) TPH staining for 5-HT specific 
cells in DRN; (3) Merged image depicting 5-HT OB projecting cells; (4) Zoomed image of co-
localized cells in DRN; white arrows show beads co-localized with 5-HT. 
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Figure 12. Cell count and co-localization of retrogradely labeled cells with 5-HT. A) Number 
of retrogradely labeled cells in DRN for Piriform Cortex (PC) and Olfactory Bulb (OB) from 
injections in two mice, one for PC and one for OB. B) Number of co-localized cells in DRN for 
each PC and OB.  C) Ratio of total retrogradely labeled cells to co-localized cells in DRN from 
PC and OB.
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Figure 13. Spatial distribution of retrogradely labeled cells for PC injections. A) Average 
number of retrogradely labeled cells as a function of location, calculated as distance from 
Bregma ( =3 mice).  B) Results n (A) were normalized by  dividing the data from each mouse by 
its maximum.   C) Zoomed image of retrogradely  labeled cells in DRN from PC; image shows 
section from one mouse with highest count of labeled cells. 
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Viruses.
 HiRet containing Pet1-Cre was injected into the PC of an ai32 transgenic mouse 
(Rosa26-LSL-ChR2H134R-EYFP) to assess virus viability and analyze transport to and 
localization in the Dorsal Raphe Nucleus.  Importantly, since Cre is under the control of the Pet1 
promoter, we expected expression of Channelrhodopsin-2 to be restricted to 5-HT neurons. 
CAV2 containing general promoter-Cre was injected into an ai32 transgenic mouse (Rosa26-
LSL-ChR2H134R-EYFP) to assess virus viability and analyze transport to and localization in the 
Dorsal Raphe Nucleus.   Using this construct with a non-specific promoter, we expected 
expression to be visible in the injection site, as well as any other regions which project to it.  A 
total of 1µl was injected into the PC, and a three week waiting time was adhered to for transport 
and expression of the virus.  Coronal sections were obtained and imaged according to protocols 
laid out in the Methods section.
 Injections.
 The injection sites were localized according to the coordinates optimized for the latex 
microsphere injections for Piriform Cortex (PC), and expression was seen locally in and near the 
PC, but no retrograde transport was visible.  If the HiRet  virus worked successfully, there should 
be no local expression since it contains a serotonin specific promoter (Pet1).  Additionally, the 
expression pattern in the PC shows patchy  patterns of eYFP expression not localized within cell 
bodies, which may indicate toxicity of virus and cell death in both cases.  Prior waiting time of 
five weeks caused a similar effect  to the cells in the injection site with the HiRet virus, therefore 
a three week waiting time was tested.  The results obtained show either three weeks waiting time 
for expression may be too long for these viruses, or the amounts of viruses injected were too 
large.  They also suggest that the Pet-1 promoter may not be specific enough and that leakage of 
expression may  confound cell-type specificity with this construct. In conclusion, further 
experiments are needed in order to obtain efficient  transport and expression of viruses from the 
PC to the DRN using these viruses or others mentioned in the Introduction section.  
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Figure 14.  Virus Injection Sites.  A) (left) Injection of HiRet virus into PC; (right) Zoomed 
image depicting infected cells in PC.  B) (left) Injection of CAV2 virus into PC; (right) Zoomed 
image depicting injected cells in PC.
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Conclusions.
 An obstacle to understanding the functional significance of 5-HT raphe neurons is the 
lack of knowledge of their precise postsynaptic targets46, as well as the functional organization of 
the DRN itself. In this study, a number of tools were used to study structural and functional 
anatomy of the DRN and its projection to various parts of the central nervous system. We were 
able to optimize the experimental protocol for retrograde labeling using latex microspheres, 
specifically the precise location of the PC was determined and found to be different from the one 
found in the atlas. The results confirmed that there are projections from the DRN to both the PC 
and the OB, and a majority  of these neurons are in fact 5-HT with PC projecting neurons being 
more numerous. These PC projecting cells were clustered in the posterior portion of the dorsal 
raphe region. More data needs to be collected and samples showing both accurate injection sites 
and optimal immunohistochemistry  staining are necessary in order to confirm the exact 
proportion of 5-HT neurons projecting to the PC out of the entire population of PC projecting 
neurons. Additional experiments with co-injections of retrograde tracers to both OB and PC 
would test the possibility that some DRN neurons project to both regions simultaneously.  
 HiRet and CAV2 viruses were also tested, though it is still unclear as to the changes that 
need to be made in order for retrograde transport and clear expression to occur within the regions 
of interest.  Optimization of the protocol is the first necessary step for using this technique in 
future retrograde and optogenetic studies.
 Recent years have seen the emergence of novel tools aimed at  studying behavior more 
specifically and with more precision (i.e., Optogentics), however this study demonstrated that in 
order to be successful, these tools need to be not only cell-type specific, but also projection-
specific in terms of 5-HT organization within the DRN.  Additionally, there needs to be a clearly 
defined layout of projections emanating from this region.  This study  could be developed further 
for future research, however with more time and precision, it could prove to be a successful 
experimental step that may inform many areas of serotonin research.
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